PYPD
NASDAQ
$4.87
Polypid Ltd (PYPD)
PolyPid Ltd., an advanced stage biopharmaceutical company, develops, manufactures and markets products based on the Polymer Lipid Encapsulation Matrix (PLEX) platform to address unmet medical needs. The company is headquartered in Petah Tikva, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $12.25 (+151.54%)
Market Cap
$87M
Free Cash Flow Yield
-32.35%
Beta (5Y)
0.46
Price Chart
Valuation
Market Cap$87M
P/B10.44
Profitability
EBITDA-$32M
EPS-$1.88
Financial Health
Debt-to-Equity9%
Free Cash Flow Yield-32.35%
Growth & Risk
FCF 5Y CAGR+4.65%
Beta (5Y)0.46
Sharpe Ratio1.36